Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-09-23FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for fexofenadine hydrochloride from Dr. Reddy's Laboratories Limited, enabling the generic produ…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Trial of STAHIST in Seasonal Allergic Rhinitis [Phase 3]
A Phase 3 trial of STAHIST for seasonal allergic rhinitis has completed, according to ClinicalTrials.gov.
-
FDA approval · 2011-06-10FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved Organon LLC's supplemental application for Singulair (montelukast sodium), granting approval of the requested supplemental acti…
-
FDA label_change · 2011-06-10FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC, likely affecting labeling and/or indications.
-
CLINICAL_TRIALS trial_result · 2011-06-03Clinical Trial Update: Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 trial evaluating efficacy and safety of omalizumab in seasonal allergic asthma and seasonal allergic rhinoconjunctivitis has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-04-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) from Organon LLC.
-
FDA approval · 2011-04-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge [Phase 2]
Phase 2 proof-of-activity trial of UR-63325 for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: Effectiveness Of Therapy With A Thermal Water Nasal Aerosol In Children With Seasonal Allergic Rhinitis [Phase 4]
A Phase 4 trial reports on the effectiveness of a thermal water nasal aerosol therapy in children with seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2011-03-25Clinical Trial Update: Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED) [Phase 3]
This document reports the completion of a Phase 3 consumer-preference study comparing two formulations of phenylephrine hydrochloride, spons…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis [Phase 1]
This Phase 1 trial update reports on the safety and tolerability of gpASIT+TM and gpASIT+TM with an Immunoregulating Adjuvant in seasonal al…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration [Phase 2]
A Phase 2 study evaluating epicutaneous immunotherapy for grass pollen allergy has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Rhinocort Aqua Versus Placebo and Fluticasone Propionate [Phase 3]
A Phase 3 trial comparing Rhinocort Aqua with placebo and with Fluticasone Propionate for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: New Nasal Applicator / New Formulation - User Study [Phase 2]
A Phase 2 user study evaluating a new nasal applicator and formulation for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit [Phase 4]
Phase 4 randomized, double-blind trial comparing single-dose fexofenadine HCl 180 mg to montelukast Na 10 mg and placebo for onset of action…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel [Phase 4]
Phase 4, single-center, randomized, double-blind, crossover trial comparing fexofenadine HCl 180 mg, cetirizine 10 mg, and placebo on cognit…
-
CLINICAL_TRIALS research · 2010-12-08Clinical Trial Update: Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients [Phase 1]
A Phase 1 clinical trial of STAHIST for seasonal allergic rhinitis has been completed. No results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2010-12-06Clinical Trial Update: Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis [Phase 2]
A Phase 2 Vienna Challenge Chamber trial evaluating RV658 for seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-08Clinical Trial Update: Safety and Tolerability Study of Ragweed SLIT Tablets [Phase 1]
A Phase 1 safety and tolerability study of ragweed pollen SLIT tablets completed, evaluating tolerability in individuals with ragweed-relate…
-
CLINICAL_TRIALS trial_result · 2010-10-11Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis [Phase 2]
Completed Phase 2 randomized, double-blind, placebo-controlled trial evaluating CVT-E002 for seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2010-09-01Clinical Trial Update: Eosinophil Markers and Development of Disease in Allergic Rhinitis
A completed clinical trial from the University of Aarhus studied eosinophil markers and their relationship to disease development. The study…
-
CLINICAL_TRIALS trial_result · 2010-08-20Clinical Trial Update: The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial evaluated nasal carbon dioxide as a treatment for seasonal allergic rhinitis and has completed. The study was spons…
-
FDA approval · 2010-08-10FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) filed by Organon LLC, resulting in labeling changes to reflect the suppl…
-
CLINICAL_TRIALS trial_result · 2010-07-29Clinical Trial Update: The Effects of Phenylephrine Compared With Those of Placebo and Pseudoephedrine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis (SAR)(P04579) [Phase 3]
Phase 3 trial comparing phenylephrine to placebo and pseudoephedrine for nasal congestion in seasonal allergic rhinitis completed with resul…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED) [Phase 3]
A completed Phase 3 placebo-controlled trial evaluating mometasone furoate nasal spray for seasonal allergic rhinitis (Study P05106).